Global life reinsurance provider Reinsurance Group of America (NYSE: RGA) announced better-than-expected revenue in Q1 CY2026, with sales up 24.3% year on year to $6.64 billion. Its non-GAAP profit of $6.97 per share was 16.3% above analysts’ consensus estimates.

Is now the time to buy RGA? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

Reinsurance Group of America’s first quarter was defined by broad-based growth across regions and a favorable claims environment, helping the company exceed Wall Street’s revenue and profit expectations. Management attributed the positive performance to strong execution in Asia Pacific, ongoing momentum in U.S. individual life and group business, and disciplined underwriting. CEO Tony Cheng highlighted, “Asia Pacific had another strong quarter, driven by ongoing growth and strong execution,” and noted that the company’s diversified global platform contributed to resilient results. Favorable economic claims experience, particularly in the U.S., also supported quarterly outcomes.

Looking forward, Reinsurance Group of America’s guidance reflects confidence in continued capital deployment, new business growth, and prudent risk management. Management is focused on leveraging its strengths in biometric risk, asset management, and global relationships to secure new deals, particularly in Asia and EMEA. CFO Axel Philippe Andre stated, “We believe that we can achieve our financial targets through this combination of capital deployment and return of capital to shareholders.” The company is also monitoring regulatory changes and evolving competitive dynamics, aiming to maintain its advantage in complex transactions that combine biometric and asset risk.

Key Insights from Management’s Remarks

Management credited the quarter’s results to robust deal activity in Asia Pacific, a strong pipeline in EMEA, and strategic underwriting initiatives in the U.S., while emphasizing capital discipline and selective transaction execution.

• Asia Pacific transaction momentum: Management highlighted successful execution of several notable transactions in Japan, including both in-force and flow deals. These transactions leveraged the company’s expertise in combining asset and biometric risk, supporting ongoing revenue growth in the region.

• Longevity business strength in EMEA: The Europe, Middle East, and Africa segment saw strong earnings from new longevity transactions and from leveraging deep client relationships. Management noted these deals helped support capital for partners and could be replicated in new markets.

• Favorable claims experience: Economic claims experience was positive across all regions, with U.S. individual life contributing over half of the benefit. Chief Risk Officer Jonathan William Porter cited moderate flu activity and improving population mortality as key factors.

• Strategic capital deployment: Management deployed $338 million into new in-force transactions and maintained a disciplined approach to capital allocation, focusing on deals offering attractive risk-adjusted returns and declining those that did not meet thresholds.

• Private credit portfolio update: The company continues to diversify its private credit portfolio, representing about 9% of total assets, with an emphasis on investment-grade and senior secured loans to provide downside protection and stable returns.

Drivers of Future Performance

Management’s outlook centers on expanding global deal pipelines, disciplined capital allocation, and evolving regulatory and competitive environments.

• Global deal pipeline expansion: Management anticipates ongoing strength in Asia, particularly Japan and Korea, as well as continued leadership in the U.K. longevity market. They also expect U.S. strategic underwriting initiatives to sustain momentum, with a focus on high-quality, high-return business.

• Capital deployment and shareholder returns: The company expects to deploy significant excess capital into new business and reduce financial leverage, while returning 20% to 30% of after-tax operating earnings to shareholders through dividends and share repurchases. Management stressed that capital allocation will remain disciplined and opportunity-driven.

• Regulatory and competitive landscape: Leadership is closely monitoring new regulations in major markets, such as the NAIC’s Actuarial Guideline 55 and proposed U.K. captive reinsurance rules. Management believes their global platform and AA-rated counterparty status should limit the impact of these changes, but they remain alert to shifting competitive dynamics from both traditional and new market entrants.

Catalysts in Upcoming Quarters

In upcoming quarters, the StockStory team will be monitoring (1) the pace of new transaction wins across Asia Pacific and EMEA, (2) the company’s continued ability to generate favorable claims experience and capitalize on underwriting strengths, and (3) the deployment of excess capital into high-return opportunities and shareholder returns. We will also keep a close watch on regulatory developments and their impact on Reinsurance Group of America’s global strategy.

Reinsurance Group of America currently trades at $211.51, in line with $212.81 just before the earnings. Is the company at an inflection point that warrants a buy or sell? See for yourself in our full research report (it’s free).

Our Favorite Stocks Right Now

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don't just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn't over. Find out which 9 stocks made the cut this week - FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.